Final Skin Notation Profiles, 44798 [2017-20126]
Download as PDF
<![CDATA[
44798
Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–17–1053; Docket No. CDC–2017–
0079]
[FR Doc. 2017–20507 Filed 9–25–17; 8:45 am]
BILLING CODE 4163–18–P
Proposed Data Collection Submitted
for Public Comment and
Recommendations
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
Centers for Disease Control and
Prevention
[CDC–2015–0021; Docket Number NIOSH–
153–C]
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on Monitoring and Reporting
System for the Division of Community
Health’s Cooperative Agreement
Programs. CDC seeks to continue the
collection of information from awardees
funded through the Racial and Ethnic
Approaches to Community health
(REACH) cooperative agreement to
provide semi-annual reports to CDC
describing their work plan, activities
and progress toward achieving
objectives during the fourth year of
funding.
SUMMARY:
Final Skin Notation Profiles
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of availability.
AGENCY:
NIOSH announces the
availability of the following 9 Skin
Notation Profile documents: 1Bromopropane [CAS No. 106–94–5],
Disulfoton [CAS No. 298–04–4],
Heptachlor [CAS No. 76–44–8], 2Hydropropyl acrylate [CAS No. 999–61–
1], Trichloroethylene [CAS No. 79–01–
7], Tetraethyl lead [CAS No. 78–00–2],
Tetramethyl lead [CAS No. 75–74–1],
Dimethyl sulfate [CAS No. 77–78–1],
Arsenic and compounds [CAS No.
7440–38–2].
DATES: The final Skin Notation Profile
documents were published on August
17, 2017.
ADDRESSES: These documents may be
obtained at the following link: https://
www.cdc.gov/niosh/topics/skin/skinnotation_profiles.html.
FOR FURTHER INFORMATION CONTACT:
Naomi Hudson, Dr. Ph.D., NIOSH,
Education and Information Division
(EID), Robert A. Taft Laboratories, 1090
Tusculum Ave., MS–C32, Cincinnati,
OH 45226, phone 513/533–8388 (not a
toll-free number), email: iuz8@cdc.gov.
SUPPLEMENTARY INFORMATION: On May 1,
2015, NIOSH published a request for
public review in the Federal Register
[80 FR 24932] on skin notation profiles
and technical documents. All comments
received were reviewed and addressed
where appropriate.
SUMMARY:
Dated: September 18, 2017.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2017–20126 Filed 9–25–17; 8:45 am]
BILLING CODE 4163–19–P
VerDate Sep<11>2014
21:09 Sep 25, 2017
Jkt 241001
Written comments must be
received on or before November 27,
2017.
DATES:
You may submit comments,
identified by Docket No. CDC–2017–
0079 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
ADDRESSES:
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the
address listed above.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE., MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 82, Number 185 (Tuesday, September 26, 2017)]
[Notices]
[Page 44798]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20126]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[CDC-2015-0021; Docket Number NIOSH-153-C]
Final Skin Notation Profiles
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of availability.
-----------------------------------------------------------------------
SUMMARY: NIOSH announces the availability of the following 9 Skin
Notation Profile documents: 1-Bromopropane [CAS No. 106-94-5],
Disulfoton [CAS No. 298-04-4], Heptachlor [CAS No. 76-44-8], 2-
Hydropropyl acrylate [CAS No. 999-61-1], Trichloroethylene [CAS No. 79-
01-7], Tetraethyl lead [CAS No. 78-00-2], Tetramethyl lead [CAS No. 75-
74-1], Dimethyl sulfate [CAS No. 77-78-1], Arsenic and compounds [CAS
No. 7440-38-2].
DATES: The final Skin Notation Profile documents were published on
August 17, 2017.
ADDRESSES: These documents may be obtained at the following link:
https://www.cdc.gov/niosh/topics/skin/skin-notation_profiles.html.
FOR FURTHER INFORMATION CONTACT: Naomi Hudson, Dr. Ph.D., NIOSH,
Education and Information Division (EID), Robert A. Taft Laboratories,
1090 Tusculum Ave., MS-C32, Cincinnati, OH 45226, phone 513/533-8388
(not a toll-free number), email: iuz8@cdc.gov.
SUPPLEMENTARY INFORMATION: On May 1, 2015, NIOSH published a request
for public review in the Federal Register [80 FR 24932] on skin
notation profiles and technical documents. All comments received were
reviewed and addressed where appropriate.
Dated: September 18, 2017.
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2017-20126 Filed 9-25-17; 8:45 am]
BILLING CODE 4163-19-P
